Keynote: Novel industrial biocatalysts from engineering/evolution

Client login

Home / Knowledge Centre /

API, Chemical Development & Analytical Services / Keynote: Novel industrial biocatalysts from engineering/evolution

Presentation

Back

Keynote: Novel industrial biocatalysts from engineering/evolution

This presentation was given by Dr. Jill Caswell, Biology Team Leader at the 2020 virtual EU Protein Engineering Congress. Jill discusses novel industrial biocatalysts from engineering/evolution which covers Almac’s approach to enzyme engineering, rational design protocols for enzyme engineering, and industrial case studies.

View Resource

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

You may also be interested in

Technical Publication

Modular Synthesis of Benzoylpyridines Exploiting a Reductive Arylation Strategy

Technical Publication

Origin of the enantioselectivity of alcohol dehydrogenase

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Presentation

Modular Synthesis of Benzoylpyridines Exploiting a Reductive Arylation Strategy

Origin of the enantioselectivity of alcohol dehydrogenase